NEW YORK--(BUSINESS WIRE)--Enzo Biochem, Inc. (NYSE:ENZ), a biotechnology company specializing in gene identification and genetic and immune regulation technologies for diagnostic and therapeutic applications and laboratory services, today announced that its subsidiary, Enzo Clinical Labs, Inc., has added two key personnel to its senior management group.
